Concepedia

Ali Tabatabaei

AT

22

Publications

970

Citations

18

H-Index

1991

Active since

Affiliations

Acadia Pharmaceuticals (United States)(Current)

University of British Columbia

Dart NeuroScience (United States)

Scripps Institution of Oceanography

Scripps (United States)

Ali Tabatabaei is an author at Acadia Pharmaceuticals (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1991–2024

22

Publications

22

Comparison of in Vitro P-Glycoprotein Screening Assays:  Recommendations for Their Use in Drug Discovery

Dietmar Schwab, Holger Fischer, Ali Tabatabaei et al. · Journal of Medicinal Chemistry · 2003 · 200 citations · Full text

Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase

Kristen A. Baltgalvis, Kelsey N. Lamb, Kent T. Symons et al. · Nature · 2024 · 88 citations

, , +6

AC-260584, an orally bioavailable M1 muscarinic receptor allosteric agonist, improves cognitive performance in an animal model

Stefania Risso Bradley, Jelveh Lameh, Linda Ohrmund et al. · Neuropharmacology · 2009 · 67 citations

, , +11

ACP-103, a 5-Hydroxytryptamine 2A Receptor Inverse Agonist, Improves the Antipsychotic Efficacy and Side-Effect Profile of Haloperidol and Risperidone in Experimental Models

Luis R. Gardell, Kimberly E. Vanover, Linda Pounds et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 57 citations

Discovery of Selective Phosphodiesterase 1 Inhibitors with Memory Enhancing Properties

Brian Dyck, Bryan J. Branstetter, Tawfik Gharbaoui et al. · Journal of Medicinal Chemistry · 2017 · 54 citations · Full text

Rows per page

1–5 of 22